BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 12360154)

  • 1. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Roy D
    Card Electrophysiol Rev; 2003 Sep; 7(3):208-10. PubMed ID: 14739714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
    Van Gelder IC; Van Veldhuisen DJ; Crijns HJ; Tuininga YS; Tijssen JG; Alings AM; Bosker HA; Cornel JH; Kamp O; Veeger NJ; Volbeda M; Rienstra M; Ranchor AV; TenVergert EM; Van den Berg MP
    Am Heart J; 2006 Sep; 152(3):420-6. PubMed ID: 16923407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I; John Camm A
    Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL; Safford RE; ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
    Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
    Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrioventricular junction ablation followed by resynchronization therapy in patients with congestive heart failure and atrial fibrillation (AVERT-AF) study design.
    Hamdan MH; Freedman RA; Gilbert EM; Dimarco JP; Ellenbogen KA; Page RL
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1081-8. PubMed ID: 17038140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of atrial fibrillation in heart failure].
    Le Heuzey JY; Marijon E; Otmani A; Lepillier A; Waintraub X; Lavergne T; Pornin M
    Therapie; 2009; 64(2):115-9. PubMed ID: 19664405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
    Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
    J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and heart failure comorbidity.
    Schuchert A
    Minerva Cardioangiol; 2005 Aug; 53(4):299-311. PubMed ID: 16177674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of atrial fibrillation].
    Fazekas T; Csanádi Z; Varró A
    Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC; Hagens VE; Bosker HA; Kingma JH; Kamp O; Kingma T; Said SA; Darmanata JI; Timmermans AJ; Tijssen JG; Crijns HJ;
    N Engl J Med; 2002 Dec; 347(23):1834-40. PubMed ID: 12466507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of atrial fibrillation in patients with heart failure.
    Neuberger HR; Mewis C; van Veldhuisen DJ; Schotten U; van Gelder IC; Allessie MA; Böhm M
    Eur Heart J; 2007 Nov; 28(21):2568-77. PubMed ID: 17855740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication.
    Bortone A; Boveda S; Pasquié JL; Pujadas-Berthault P; Marijon E; Appetiti A; Albenque JP
    Europace; 2009 Aug; 11(8):1018-23. PubMed ID: 19556251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.